Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Amer, Mohamed S ^a,b,e   Li, Jing ^a,b   O'Regan, David J ^d   Steele, Derek S ^a,b   Porter, Karen E ^a,c   Sivaprasadarao, Asipu ^a,b   Beech, David J ^a,b,c  

^a Chapel Allerton Hospital   (United Kingdom)

^b Faculty of Biological Sciences   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Blood vessels; Calcium stores; Remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANISOMYCIN; CALCIUM; EMETINE; ENDOTHELIN 1; FURA 2; METHIONINE; PUROMYCIN; THAPSIGARGIN; TRANSLOCON; ENZYME INHIBITOR; IONOMYCIN; MEMBRANE PROTEIN; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ANISOMYCIN; CALCIUM; CALCIUM SIGNALING; CELL PROLIFERATION; CELLS, CULTURED; EMETINE; ENDOPLASMIC RETICULUM; ENDOTHELIN-1; ENZYME INHIBITORS; HUMANS; IONOMYCIN; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; THAPSIGARGIN;

EID: 66249116682     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00984.2008     Document Type: Article

References (35)

1. Angelini GD, Jeremy JY. Towards the treatment of saphenous vein bypass graft failure-a perspective of the Bristol Heart Institute. Biorheology 39: 491-499, 2002.
2. Beech DJ. Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans 35: 890-894, 2007.
3. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81: 999-1030, 2001.
4. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295: C779-C790, 2008.
5. Borna C, Wang L, Gudbjartsson T, Karlsson L, Jern S, Malmsjo M, Erlinge D. Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg 76: 50-57, 2003.
6. Croons V, Martinet W, Herman AG, De Meyer GR. Differential effect of the protein synthesis inhibitors puromycin and cycloheximide on vascular smooth muscle cell viability. J Pharmacol Exp Ther 325: 824-832, 2008.
7. Davenport AP, Maguire JJ. The endothelin system in human saphenous vein graft disease. Curr Opin Pharmacol 1: 176-182, 2001.
8. 2+ pumps. Cell Calcium 26: 9-13, 1999.
9. 2-pathway regulated store operated channels activation. FASEB J 20: 1215-1217, 2006.
10. 2+ leak from the endoplasmic reticulum: a mechanistic study on rat liver microsomes. Arch Biochem Biophys 462: 115-121, 2007.
11. 2+ entry in human arterial myocytes. Am J Physiol Cell Physiol 277: C343-C349, 1999.
12. Haigh NG, Johnson AE. A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane. J Cell Biol 156: 261-270, 2002.
13. Hamman BD, Hendershot LM, Johnson AE. BiP maintains the permeability barrier of the ER membrane by sealing the lumenal end of the translocon pore before and early in translocation. Cell 92: 747-758, 1998.
14. Heritage D, Wonderlin WF. Translocon pores in the endoplasmic reticulum are permeable to a neutral, polar molecule. J Biol Chem 276: 22655-22662, 2001.
15. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Plügers Arch 456: 769-785, 2008.
16. Lizak B, Czegle I, Csala M, Benedetti A, Mandl J, Banhegyi G. Translocon pores in the endoplasmic reticulum are permeable to small anions. Am J Physiol Cell Physiol 291: C511-C517, 2006.
17. 2+ leak from the endoplasmic reticulum of pancreatic acinar cells. Second messenger-activated channels and translocons. J Biol Chem 277: 26479-26485, 2002.
18. MacInnes JW, Luttges MW. Interactive effects of cycloheximide and puromycin in altering brain polyribosomes and neutral and behavioural responses to electroshock in mice. J Neurochem 21: 775-781, 1973.
19. 2+ channel: from discovery to new signaling concepts. J Neurochem 102: 1426-1446, 2007.
20. 2+-overloaded cultured rat portal vein myocytes. J Biol Chem 276: 11257-11264, 2001.
21. 2+ stores in permeabilized A7r5 cells. Cell Calcium 29: 111-116, 2001.
22. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol 59: 232-239, 2006.
23. 2+ leak function of presenilin 1. J Clin Invest 117: 1230-1239, 2007.
24. 2+ release via the ER translocon activates store-operated calcium entry. Pflügers Arch 453: 797-808, 2007.
25. Owens GK, Kumar MS,Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004.
26. Pestka S. Inhibitors of ribosome functions. Annu Rev Microbiol 25: 487-562, 1971.
27. Roy A,WonderlinWF. The permeability of the endoplasmic reticulum is dynamically coupled to protein synthesis. J Biol Chem 278: 4397-4403, 2003.
28. 2+-ATPase. Proc Natl Acad Sci USA 87: 2466-2470, 1990.
29. 2+-ATPases. Trends Pharmacol Sci 19: 131-135, 1998.
30. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126: 981-993, 2006.
31. 2+ handling in vascular smooth muscle cells is affected by proliferation. Arterioscler Thromb Vasc Biol 20: 1225-1235, 2000.
32. Van Coppenolle F, Vanden Abeele F, Slomianny C, Flourakis M, Hesketh J, Dewailly E, Prevarskaya N. Ribosome-translocon complex mediates calcium leakage from endoplasmic reticulum stores. J Cell Sci 117: 4135-4142, 2004.
33. Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol 2: 499-516, 1986.
34. Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, Shah S, Dedman AM, Flemming PK, McHugh D, Naylor J, Cheong A, Bateson AN, Munsch CM, Porter KE, Beech DJ. A sphingosine-1-phosphate-activated cal-cium channel controlling vascular smooth muscle cell motility. Circ Res 98: 1381-1389, 2006.
35. Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem 76: 367-385, 2007.